Utilities

EMERA and Innate Pharma partner to fast‑track lacutamab, a first‑in‑class anti‑KIR3DL2 antibody, for rare cutaneous T‑cell lymphoma, promising accelerated approval and global market access.

Hong Kong insurers deepen mainland brokerage ties—boosting cross‑border services, cutting regulatory barriers, and tapping high‑net‑worth demand for new growth.

Explore how American Water Works’ disciplined capital allocation and regulatory strategy drive resilient profits, and why those lessons shape grid upgrades and renewable integration across utilities.

Power Assets Holdings Ltd shows solid revenue growth & solid margins, but faces regulatory costs, debt pressure and rising storage competition. Understand the risks and growth opportunities.

Constellation Energy Corp. reports a modest share purchase by director Roger Crandall, confirming routine ownership activity and no impact on governance or strategy.

Ørsted stays financially solid and grid‑savvy, driving offshore wind, solar and battery upgrades to secure revenue certainty while easing future consumer costs.

RWE’s $1.25 billion settlement ends U.S. offshore wind leases, redirecting funds to LNG and peaker plants—shifting its renewable‑energy stance toward fossil‑fuel projects.

German stocks edge higher amid energy uncertainty, spotlighting tech resilience, utility headwinds, and EV‑driven auto gains.

Explore Duke Energy’s 3% rate‑increase settlement in North Carolina: lower revenue hike, refunds on capital projects, and $10M for low‑income support—what it means for customers and investors.

SEC filings show NRG Energy’s executives buying stock, but the real story is its $4 billion grid upgrade plan and 15 GW of renewables to boost reliability and future profits.